These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7594815

  • 1. Whole-body hyperthermia and lonidamine as adjuvant therapy to treatment with cisplatin with or without local radiation in mouse bearing the Lewis lung carcinoma.
    Teicher BA, Holden SA, Ara G, Menon K.
    Int J Hyperthermia; 1995; 11(5):637-45. PubMed ID: 7594815
    [Abstract] [Full Text] [Related]

  • 2. Whole-body hyperthermia as an adjuvant to treatment with platinum complexes with or without etanidazole in mice bearing the Lewis lung carcinoma or the FSaLL fibrosarcoma.
    Teicher BA, Herman TS, Menon K, Korbut TT.
    Int J Hyperthermia; 1992; 8(6):783-94. PubMed ID: 1479204
    [Abstract] [Full Text] [Related]

  • 3. Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment.
    Overgaard J, Radacic M, Skaric D, Skaric V, Horsman MR, Lindegaard JC, Jercic J.
    Int J Hyperthermia; 1993; 9(6):821-30. PubMed ID: 8106823
    [Abstract] [Full Text] [Related]

  • 4. [Influence of local hyperthermia combined with radiation on tumor growth and lung metastases of transplantable Lewis lung carcinoma growing in hind legs].
    Ohizumi Y, Maezawa H, Mori T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Apr 25; 49(4):468-76. PubMed ID: 2798049
    [Abstract] [Full Text] [Related]

  • 5. Sensitization of combined cis-platinum and cyclophosphamide by local hyperthermia in mice bearing the Lewis lung carcinoma.
    Hazan G, Lurie H, Yerushalmi A.
    Oncology; 1984 Apr 25; 41(1):68-9. PubMed ID: 6538329
    [Abstract] [Full Text] [Related]

  • 6. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA, Pfeffer MR, Alvarez Sotomayor E, Herman TS.
    Int J Hyperthermia; 1991 Apr 25; 7(5):773-84. PubMed ID: 1834752
    [Abstract] [Full Text] [Related]

  • 7. A prospective randomized comparison of radiation therapy plus lonidamine versus radiation therapy plus placebo as initial treatment of clinically localized but nonresectable nonsmall cell lung cancer.
    Scarantino CW, McCunniff AJ, Evans G, Young CW, Paggiarino DA.
    Int J Radiat Oncol Biol Phys; 1994 Jul 30; 29(5):999-1004. PubMed ID: 8083102
    [Abstract] [Full Text] [Related]

  • 8. Radiation enhanced efficiency of combined electromagnetic hyperthermia and chemotherapy of lung carcinoma using cisplatin functionalized magnetic nanoparticles.
    Babincová M, Kontrisova K, Durdík S, Bergemann C, Sourivong P.
    Pharmazie; 2014 Feb 30; 69(2):128-31. PubMed ID: 24640602
    [Abstract] [Full Text] [Related]

  • 9. Combined modality clinical trials for favorable B-cell neoplasms: lonidamine plus whole body hyperthermia and/or total body irradiation.
    Robins HI.
    Semin Oncol; 1991 Apr 30; 18(2 Suppl 4):23-7. PubMed ID: 2031194
    [Abstract] [Full Text] [Related]

  • 10. [Experimental studies on effects of total-body and local hyperthermia on metastases in mice].
    Oda M.
    Nihon Geka Gakkai Zasshi; 1985 Feb 30; 86(2):121-31. PubMed ID: 3920500
    [Abstract] [Full Text] [Related]

  • 11. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
    Bergs JW, Haveman J, Ten Cate R, Medema JP, Franken NA, Van Bree C.
    Oncol Rep; 2007 Jul 30; 18(1):219-26. PubMed ID: 17549371
    [Abstract] [Full Text] [Related]

  • 12. Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations.
    Robins HI, Longo WL, Steeves RA, Cohen JD, Schmitt CL, Neville AJ, O'Keefe S, Lagoni R, Riggs C.
    Int J Radiat Oncol Biol Phys; 1990 Apr 30; 18(4):909-20. PubMed ID: 2182581
    [Abstract] [Full Text] [Related]

  • 13. Combined hyperthermia and immunotherapy treatment of multiple pulmonary metastases in mice.
    Strauch ED, Fabian DF, Turner J, Lefor AT.
    Surg Oncol; 1994 Feb 30; 3(1):45-52. PubMed ID: 8186870
    [Abstract] [Full Text] [Related]

  • 14. Phase I trial of lonidamine with whole body hyperthermia in advanced cancer.
    Robins HI, Longo WL, Lagoni RK, Neville AJ, Hugander A, Schmitt CL, Riggs C.
    Cancer Res; 1988 Nov 15; 48(22):6587-92. PubMed ID: 3180069
    [Abstract] [Full Text] [Related]

  • 15. [Experimental foundation of using intraoperative endopelvic cisplatin with hyperthermia for rectal cancer].
    Shelygin IuA, Alekseev MV, Rybakov EG, Pankratov AA, Pliushinskaia AD.
    Vopr Onkol; 2010 Nov 15; 56(2):191-5. PubMed ID: 20552896
    [Abstract] [Full Text] [Related]

  • 16. Combination and individual antitumor effects of hyperthermia, cisplatin, and selected dithiocarbamates.
    Walker EM, Schaefer RF, Henle KJ, Schmidt BJ, Gale GR, Cannon DJ, Jones MM, Moss AJ.
    Ann Clin Lab Sci; 1989 Nov 15; 19(4):242-54. PubMed ID: 2757352
    [Abstract] [Full Text] [Related]

  • 17. The interaction of cisplatin plus etoposide with radiation +/- hyperthermia.
    Pfeffer MR, Teicher BA, Holden SA, al-Achi A, Herman TS.
    Int J Radiat Oncol Biol Phys; 1990 Dec 15; 19(6):1439-47. PubMed ID: 2262368
    [Abstract] [Full Text] [Related]

  • 18. Morphological damage induced in vivo by Lonidamine on human metastatic cancer cells.
    De Martino C, Battelli T, Cavaliere R, Gallo Curcio C, Bellocci M, Manocchi D, Giustini L, Mattioli R, Rinaldi M, Di Filippo F.
    Oncology; 1984 Dec 15; 41 Suppl 1():94-103. PubMed ID: 6717904
    [Abstract] [Full Text] [Related]

  • 19. Temporal interactions in the Lewis lung tumour between cytotoxic drugs and acute or fractionated radiotherapy.
    Stephens TC, Adams K, Peacock JH, Steel GG.
    Radiother Oncol; 1986 Feb 15; 5(2):137-46. PubMed ID: 3704188
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft.
    Pratesi G, De Cesare M, Zunino F.
    Cancer Chemother Pharmacol; 1996 Feb 15; 38(2):123-8. PubMed ID: 8616901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.